Muscarinic antagonist effects on executive control of attention.
Thienel R, Kellermann T, Schall U, Voss B, Reske M, Halfter S, Sheldrick AJ, Radenbach K, Habel U, Shah NJ, Kircher T.
Thienel R, et al.
Int J Neuropsychopharmacol. 2009 Nov;12(10):1307-17. doi: 10.1017/S146114570999068X. Epub 2009 Oct 1.
Int J Neuropsychopharmacol. 2009.
PMID: 19793402
Free article.
Clinical Trial.